BLSM insider buying
Every open-market purchase of BlossomHill Therapeutics, Inc. (BLSM) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$25.18M
Insiders buying (12m)6
Purchases on record6
Last purchase filedAug 12, 2026
In the last 12 months, 6 insiders of BlossomHill Therapeutics, Inc. bought $25.18M of BLSM stock on the open market in 6 reported purchases. The most recent was filed on Aug 12, 2026: Gordon Carl L (Director) bought 625,000 shares at $16.00, worth $10M.
Get the next BLSM insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll BLSM insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Aug 12 | Gordon Carl LDirector | $10M | 625,000 | $16.00 | +30% | Aug 10 | SEC |
| Aug 12 | OrbiMed Capital GP VIII LLC +1Director | $10M | 625,000 | $16.00 | +30% | Aug 10 | SEC |
| Aug 10 | Liptak Vincent PaulGeneral Counsel | $74.70K | 4,700 | $15.89 | +4% | Aug 7 | SEC |
| Aug 10 | Keyes Jason AChief Financial Officer | $11.20K | 700 | $16.00 | new | Aug 10 | SEC |
| Aug 10 | Schmid John P.Director | $96K | 6,000 | $16.00 | new | Aug 10 | SEC |
| Aug 10 | Cormorant Private Healthcare…10% Owner | $5M | 312,500 | $16.00 | +10% | Aug 10 | SEC |